Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

walgreen co - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication for the treatment of acne - have very sensitive skin - are sensitive to benzoyl peroxide irritation becomes severe

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

zo skin health, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication for the treatment of acne.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

lacer pharma, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - enzoclear™ foam is indicated for use in the topical treatment of mild to moderate acnes vulgaris. enzoclear™ foam should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. discontinue use if hypersensitivity is observed.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

kroger - benzoyl peroxide 10% - acne medication for the treatment of acne - have very sensitive skin - are sensitive to benzoyl peroxide irritation becomes severe

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

topiderm, inc. - benzoyl peroxide usp, 10% - acne treatment bp wash is a therapeutic combination of sudsing cleanser and benzoyl peroxide for the treatment of acne.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

global pharma healthcare private limited - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne treatment for the treatment of acne

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

global pharma healthcare private limited - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne treatment for the treatment of acne

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

beauty manufacturing solutions corp - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication - for the treatment of acne - dries and clears acne blemishes and allows skin to heal - have very sensitive skin - are sensitive to benzoyl peroxide irritation becomes severe

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

galderma laboratories, l.p. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - epsolay is indicated for the treatment of inflammatory lesions of rosacea in adults. epsolay is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in epsolay [see warnings and precautions (5.1) ]. risk summary the systemic exposure of benzoyl peroxide is unknown. based on the published literature, benzoyl peroxide is metabolized to benzoic acid (an endogenous substance), which is eliminated in the urine. hence, maternal use is not expected to result in fetal exposure to the drug. animal reproductive studies have not been conducted with epsolay or benzoyl peroxide. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk su

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

sol-gel technologies inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - epsolay is indicated for the treatment of inflammatory lesions of rosacea in adults. epsolay is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in epsolay [see warnings and precautions (5.1)]. risk summary the systemic exposure of benzoyl peroxide is unknown. based on the published literature, benzoyl peroxide is metabolized to benzoic acid (an endogenous substance), which is eliminated in the urine. hence, maternal use is not expected to result in fetal exposure to the drug. animal reproductive studies have not been conducted with epsolay or benzoyl peroxide. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk s